Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Kerry L. Reynolds"'
Autor:
Deirdre F. Sheehan, Justin F. Gainor, Meghan J. Mooradian, Steven D. Criss, Kerry L. Reynolds, Leyre Zubiri, Chung Yin Kong, Melissa A. Lumish
Publikováno v:
JAMA Oncology. 5:358
Importance In early 2018, durvalumab became the first immunotherapy to be approved for adjuvant treatment of patients with unresectable stage III non–small cell lung cancer (NSCLC) whose cancer has not progressed after definitive chemoradiotherapy.